Reuters logo
BRIEF-Biotest recalls human albumin and reduces forecast
April 26, 2017 / 3:47 PM / 7 months ago

BRIEF-Biotest recalls human albumin and reduces forecast

April 26 (Reuters) - Biotest AG:

* Recalls human albumin and reduces forecast

* Performed a batch recall of human albumin (Albiomin(R)) 5 percent and 20 percent Biotest injection solution

* Batches in question had already been quarantined by Biotest on April 13, 2017

* As a precautionary measure, reduces its sales guidance from single-digit growth rate to level of previous year and its EBIT guidance of 46 million euros to 48 million euros ($49.95 million - $52.12 million) by 25 million to 30 million euros Source text for Eikon: Further company coverage: ($1 = 0.9209 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below